Betsy Gross

Vice President, Global Market Access at Intersect ENT, Inc.

Betsy Gross

Betsy Gross

Vice President, Global Market Access at Intersect ENT, Inc.

Biography

Betsy has over 25 years of experience supporting technology commercialization across various specialties in the biotech and medical device industries. Prior to Intersect ENT, Betsy was Director of Health Economics and Reimbursement at Acclarent, a Johnson & Johnson company, where she led payor coverage policy initiatives to expand patient access to Balloon Sinuplasty™. Previously, she was responsible for the strategic reimbursement direction of Edwards Lifesciences’ Heart Valve Therapy, Critical Care, Cardiac Surgery Systems and Vascular Business units for products from development through commercialization in both US and OUS markets. She worked in similar capacities for Cyberonics and Medtronic’s Neurological business unit. Betsy is a Registered Nurse with a B.S. in Nursing from Villanova University and she is a Certified Professional Coder with additional certifications in hospital and ENT coding.

Overview
RelSci Relationships

61

Contact Data
Trying to get in touch with Betsy Gross? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Betsy Gross likely has professional access to. A relationship does not necessarily indicate a personal connection.

Head-Media Relations at Intersect ENT, Inc.

Relationship likelihood: Average

Director of Supply Chain at Intersect ENT, Inc.

Relationship likelihood: Average

Former Chief People Officer at Intersect ENT, Inc.

Relationship likelihood: Average

Vice President, Regulatory Affairs at Intersect ENT, Inc.

Relationship likelihood: Average

Vice President, Healthcare Economics & Reimbursement at Intersect ENT, Inc.

Relationship likelihood: Average

Director, President & Chief Executive Officer at Intersect ENT, Inc.

Relationship likelihood: Average

Chief Financial Officer & Executive Vice President at Intersect ENT, Inc.

Relationship likelihood: Average

Former Chairman at Intersect ENT, Inc.

Relationship likelihood: Average

Executive Vice President, Medical Devices at Abbott Laboratories

Relationship likelihood: Average

Former Senior Vice President, Operations at ev3 LLC

Relationship likelihood: Average

Paths to Betsy Gross
Potential Connections via
Relationship Science
You
Betsy Gross
Vice President, Global Market Access at Intersect ENT, Inc.
Career History
Vice President, Global Market Access
Current

Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA.

Other Affiliations

Betsy Gross is affiliated with Intersect ENT, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Betsy Gross. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Betsy Gross's profile does not indicate a business or promotional relationship of any kind between RelSci and Betsy Gross.